This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - P/B ratio
P/B ratio as of March 2025 : 2.34
According to KemPharm's latest financial reports the company has a price-to-book ratio of 19.1694.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
KemPharm - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.85 | -23.05% |
| 2021-12-31 | 2.40 | -413.46% |
| 2020-12-31 | -0.7652 | 313.21% |
| 2019-12-31 | -0.1852 | -73.82% |
| 2018-12-31 | -0.7074 | -31.46% |
| 2017-12-31 | -1.03 | -55.34% |
| 2016-12-31 | -2.31 | -91.87% |
| 2015-12-31 | -28.4 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 2.09 | -10.74% | 🇮🇪 Ireland |
 | -0.4758 | -120.37% | 🇺🇸 USA |
 | 2.49 | 6.75% | Cayman Islands |
 | 3.27 | 39.88% | 🇺🇸 USA |